TNSN96021A1 - SUBSTITUTED INDOLES - Google Patents
SUBSTITUTED INDOLESInfo
- Publication number
- TNSN96021A1 TNSN96021A1 TNTNSN96021A TNSN96021A TNSN96021A1 TN SN96021 A1 TNSN96021 A1 TN SN96021A1 TN TNSN96021 A TNTNSN96021 A TN TNSN96021A TN SN96021 A TNSN96021 A TN SN96021A TN SN96021 A1 TNSN96021 A1 TN SN96021A1
- Authority
- TN
- Tunisia
- Prior art keywords
- substituted indoles
- medicinal products
- appropriate
- indoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Abstract
ON PREPARE DES INDOLES SUBSTITUES EN FAISANT REAGIR AVEC DES AMINES APPROPRIEES DES ACIDES CARBOXYLIQUES APPROPRIES, EVENTUELLEMENT EN PRESENCE DE SUBSTANCES AUXILIAIRES. LES INDOLES SUBSTITUES CONVIENNENT COMME PRINCIPES ACTIFS DANS DES MEDICAMENTS, EN PARTICULIER DANS LES MEDICAMENTS DESTINES AU TRAITEMENT DE L'ARTERIOSCLEROSE ET DE LA RESTENOSESUBSTITUTED INDOLES ARE PREPARED BY REACTING WITH APPROPRIATE AMINES OF APPROPRIATE CARBOXYLIC ACIDS, POSSIBLY IN THE PRESENCE OF AUXILIARY SUBSTANCES. SUBSTITUTED INDOLES ARE SUITABLE AS ACTIVE INGREDIENTS IN MEDICINAL PRODUCTS, PARTICULARLY IN MEDICINAL PRODUCTS FOR THE TREATMENT OF ARTERIOSCLEROSIS AND RESTENOSIS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19503159 | 1995-02-01 | ||
DE19513716A DE19513716A1 (en) | 1995-02-01 | 1995-04-11 | Substituted 2-phenylindole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN96021A1 true TNSN96021A1 (en) | 2005-03-15 |
Family
ID=7752848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN96021A TNSN96021A1 (en) | 1995-02-01 | 1996-02-01 | SUBSTITUTED INDOLES |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR960031439A (en) |
DE (2) | DE19513716A1 (en) |
MY (1) | MY132270A (en) |
RU (1) | RU2162842C2 (en) |
SG (1) | SG38925A1 (en) |
SV (1) | SV1996000009A (en) |
TN (1) | TNSN96021A1 (en) |
TW (1) | TW349092B (en) |
YU (1) | YU5796A (en) |
ZA (1) | ZA96726B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2517659A1 (en) * | 1975-04-22 | 1976-11-11 | Merck Patent Gmbh | INDOLDER DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION |
DE3739882A1 (en) * | 1987-11-25 | 1989-06-08 | Bayer Ag | SUBSTITUTED HYDROXYLAMINE |
US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
-
1995
- 1995-04-11 DE DE19513716A patent/DE19513716A1/en not_active Withdrawn
-
1996
- 1996-01-19 DE DE59605373T patent/DE59605373D1/en not_active Expired - Fee Related
- 1996-01-22 TW TW085100681A patent/TW349092B/en active
- 1996-01-29 MY MYPI96000315A patent/MY132270A/en unknown
- 1996-01-30 YU YU5796A patent/YU5796A/en unknown
- 1996-01-31 KR KR1019960002343A patent/KR960031439A/en not_active Application Discontinuation
- 1996-01-31 RU RU96101801/04A patent/RU2162842C2/en active
- 1996-01-31 ZA ZA96726A patent/ZA96726B/en unknown
- 1996-02-01 SG SG1996000770A patent/SG38925A1/en unknown
- 1996-02-01 TN TNTNSN96021A patent/TNSN96021A1/en unknown
- 1996-02-01 SV SV1996000009A patent/SV1996000009A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE19513716A1 (en) | 1996-08-08 |
SG38925A1 (en) | 1997-04-17 |
RU2162842C2 (en) | 2001-02-10 |
SV1996000009A (en) | 1996-11-14 |
YU5796A (en) | 1999-03-04 |
MY132270A (en) | 2007-09-28 |
KR960031439A (en) | 1996-09-17 |
DE59605373D1 (en) | 2000-07-13 |
ZA96726B (en) | 1996-08-20 |
TW349092B (en) | 1999-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN97048A1 (en) | PYRIDINES 2 - ARYL - SUBSTITUTED. | |
TNSN96035A1 (en) | N- (3-BENZOFURANNYL) UREA DERIVATIVES | |
DE69737719D1 (en) | SUBSTITUTED GAMMA AMINOBUTTERIC ACID DERIVATIVES AS DRUGS | |
CA2217515A1 (en) | Pharmaceutical composition containing proton pump inhibitors | |
AU6563596A (en) | Treatment of tinnitis using neuroprotective agents | |
DE69331739D1 (en) | INNOVATIVE PHARMACEUTICAL USES OF KRILL ENZYMS | |
MX9602973A (en) | Use of bradyquinine antagonist in a cosmetic, pharmaceutical or dermatological composition, and composition obtained therefrom. | |
ATE215373T1 (en) | 21-HYDRO-6,19-OXIDOPROGESTERONE (21OH-60P) AND THEIR USE AS A MEDICINAL PRODUCT FOR THE TREATMENT OF GLUCOCORTICOID EXCESS | |
TNSN96005A1 (en) | 2-(2-n-alcoxyphenyl)-purine-6-ones 9-substituees | |
DK0562705T3 (en) | Use of L-deprenyl in the manufacture of a drug for the treatment of Cushing's disease | |
DE69632396D1 (en) | TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR | |
MX9403088A (en) | Indole derivatives. | |
DE59610175D1 (en) | HYDANTO DERIVATIVES AS INTERMEDIATE PRODUCTS FOR PHARMACEUTICAL ACTIVE SUBSTANCES | |
TNSN96016A1 (en) | USE OF PHENYLCYCLOHEXYLCARBOXAMIDES | |
IT1276162B1 (en) | GERANYLGERANIL DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS | |
DE69612056T2 (en) | TERPEN DERIVATIVES (SARCODICTYINE) AS AN ANTICRECELLENT | |
TNSN96021A1 (en) | SUBSTITUTED INDOLES | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
ATE181324T1 (en) | SECO-D STEROIDS ACTIVE IN THE CARDIOVASCULAR SYSTEM AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | |
ITMI922742A0 (en) | COMPOUNDS WITH THERAPEUTIC ACTIVITY USEFUL FOR THE TREATMENT OF DISEASES RELATED TO GLUTATHIONE DEFICIENCY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ATE232541T1 (en) | BALE ACID SALTS WITH PHYSIOLOGICALLY ACTIVE METALS AND THEIR USE FOR THERAPEUTIC TREATMENT | |
ATE175971T1 (en) | WATER SOLUBLE RETINOIDS | |
IT1312090B1 (en) | INACTIVATED MICROORGANISMS INCLUDING SOLUBLE AND / SOLUBILIZABLE SUBSTANCES FOR PHARMACOLOGICAL ACTIVITY AND / OR NUTRITIONAL SUBSTANCES | |
GR3031908T3 (en) | Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same | |
DE69705772T2 (en) | Adamantyl substituted oxindoles as active pharmaceutical ingredients |